Elite Pharmaceuticals Inc (ELTP)
0.6168
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Elite Pharmaceuticals Shares Outstanding: 1.068B for Nov. 14, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 14, 2024 | 1.068B |
September 30, 2024 | 1.068B |
August 12, 2024 | 1.068B |
June 30, 2024 | 1.068B |
June 26, 2024 | 1.068B |
March 31, 2024 | 1.068B |
February 14, 2024 | 1.018B |
December 31, 2023 | 1.018B |
November 14, 2023 | 1.014B |
September 30, 2023 | 1.014B |
August 14, 2023 | 1.014B |
July 25, 2023 | 1.014B |
June 30, 2023 | 1.014B |
June 23, 2023 | 1.014B |
June 20, 2023 | 1.014B |
March 31, 2023 | 1.014B |
February 14, 2023 | 1.014B |
December 31, 2022 | 1.014B |
November 14, 2022 | 1.014B |
September 30, 2022 | 1.014B |
August 15, 2022 | 1.011B |
June 30, 2022 | 1.011B |
June 23, 2022 | 1.011B |
March 31, 2022 | 1.011B |
February 11, 2022 | 1.011B |
Date | Value |
---|---|
December 31, 2021 | 1.011B |
November 15, 2021 | 1.011B |
September 30, 2021 | 1.011B |
August 13, 2021 | 1.011B |
June 30, 2021 | 1.011B |
June 07, 2021 | 1.009B |
March 31, 2021 | 1.009B |
February 11, 2021 | 1.009B |
December 31, 2020 | 1.009B |
November 10, 2020 | 1.009B |
September 30, 2020 | 1.009B |
August 10, 2020 | 846.95M |
June 30, 2020 | 840.98M |
June 24, 2020 | 840.40M |
June 23, 2020 | 840.40M |
April 27, 2020 | 840.40M |
March 31, 2020 | 840.40M |
February 04, 2020 | 839.19M |
December 31, 2019 | 833.85M |
November 05, 2019 | 832.84M |
October 07, 2019 | 832.94M |
September 30, 2019 | 832.84M |
August 02, 2019 | 828.89M |
June 30, 2019 | 828.89M |
June 07, 2019 | 828.39M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
833.85M
Minimum
Dec 31 2019
1.068B
Maximum
Mar 31 2024
988.70M
Average
1.011B
Median
Jun 30 2021
Shares Outstanding Benchmarks
Biomarin Pharmaceutical Inc | 190.58M |
BioCardia Inc | 4.584M |
Zevra Therapeutics Inc | 53.38M |
Verrica Pharmaceuticals Inc | 45.60M |
Terns Pharmaceuticals Inc | 84.94M |